The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracture
- Piet Geusens*
- , Wim van Hul
- , Joop van den Bergh
- , Willem Lems
*Corresponding author for this work
- Hasselt University
- Maastricht University
- University of Antwerp
- VieCuri Medisch Centrum
- Amsterdam UMC - University of Amsterdam
Research output: Contribution to journal › Article › Academic › peer-review
7
Downloads
(Pure)